Morgan Stanley Prime Medicine, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Morgan Stanley holds 300,391 shares of PRME stock, worth $871,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300,391

Previous 183,965 63.29%

Holding current value

$871,133

Previous $945,000 22.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.41 - $6.7 $397,012 - $780,054	116,426 Added 63.29%	300,391 $1.16 Million
Q2 2024 Oct 17, 2024	SELL	$4.3 - $8.03 $62,354 - $116,443	-14,501 Reduced 7.31%	183,965 $945,000
Q2 2024 Aug 14, 2024	SELL	$4.3 - $8.03 $62,354 - $116,443	-14,501 Reduced 7.31%	183,965 $945,000
Q1 2024 Oct 17, 2024	BUY	$6.35 - $9.39 $92,081 - $136,164	14,501 Added 7.88%	198,466 $1.39 Million
Q1 2024 Aug 16, 2024	SELL	$6.35 - $9.39 $84,251 - $124,586	-13,268 Reduced 6.27%	198,466 $1.39 Million
Q1 2024 May 15, 2024	SELL	$6.35 - $9.39 $84,251 - $124,586	-13,268 Reduced 6.27%	198,466 $1.39 Million
Q4 2023 Aug 16, 2024	BUY	$5.59 - $9.55 $155,228 - $265,193	27,769 Added 15.09%	211,734 $1.88 Million
Q4 2023 Feb 13, 2024	BUY	$5.59 - $9.55 $944,391 - $1.61 Million	168,943 Added 394.81%	211,734 $1.88 Million
Q3 2023 Nov 15, 2023	SELL	$9.5 - $15.07 $143,811 - $228,129	-15,138 Reduced 26.13%	42,791 $408,000
Q2 2023 Aug 14, 2023	BUY	$11.41 - $17.05 $280,047 - $418,475	24,544 Added 73.52%	57,929 $848,000
Q1 2023 May 15, 2023	BUY	$11.21 - $21.11 $145,685 - $274,345	12,996 Added 63.74%	33,385 $410,000
Q4 2022 Feb 14, 2023	BUY	$15.2 - $21.12 $309,912 - $430,615	20,389 New	20,389 $378,000

Others Institutions Holding PRME

# of Institutions

123

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $278M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account